Last update 23 Jan 2025

BRD4 x CLL-1

Basic Info

Related Targets
BRD4CLL-1

Related

1
Drugs associated with BRD4 x CLL-1
BRD4-Targeting DAC(Genentech)
Target
BRD4 x CLL-1
Mechanism
BRD4 degraders [+1]
Active Org.
Genentech, Inc.Genentech, Inc.
Originator Org.
Genentech, Inc.Genentech, Inc.
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with BRD4 x CLL-1
Login to view more data
100 Translational Medicine associated with BRD4 x CLL-1
Login to view more data
0 Patents (Medical) associated with BRD4 x CLL-1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free